The ADAM family comprises zinc-dependent metalloproteinases critical for regulating cellular processes through ectodomain shedding of membrane-bound proteins. These transmembrane Glycosyl Functional Enzymes feature disintegrin, metalloproteinase, and cysteine-rich domains, enabling functions like cell adhesion, migration, and signal transduction. ADAMs modulate pathways including Notch, EGFR, and TNFα signaling by cleaving substrates such as cytokines, growth factors, and adhesion molecules. Dysregulation of Glycocalyx-Degrading Enzymes, such as ADAM10, ADAM17, and ADAM9, is implicated in cancer progression, inflammation, and viral infections, making them promising therapeutic targets for diseases like autoimmune disorders and solid tumors.

Fig. 1. Transmembrane vs. soluble ADAMs: domain architecture comparison. (OA Literature) Fig.1 Structure of ADAMs of transmembrane and soluble ADAMs.¹

Service Overview

Are you grappling with persistent hurdles in antibody development against challenging transmembrane proteases, struggling with suboptimal protein yields, or facing selectivity bottlenecks among conserved metalloproteinase domains? Our ADAM development service empowers you to overcome these obstacles by delivering high-affinity modulators and bioactive sheddases with unparalleled precision. Through our proprietary expression logic, optimized for membrane protein stability and functional integrity, and AI-driven, domain-specific screening platforms, we unlock targets previously deemed undruggable.

Explore How We Can Meet Your Needs

ADAM Development Workflow

Step 1

Construct Design & Precision Optimization

Our team of experts employs advanced codon optimization strategies tailored to the specific host organism, ensuring maximum translation efficiency. Alongside this, we conduct exhaustive signal peptide screening to identify the optimal sequence for enhancing protein secretion and facilitating proper folding. This dual-pronged approach sets the foundation for high-quality protein production right from the start.

Step 2

Host Cell Engineering & High-Efficiency Expression

Leveraging our proprietary platform, we embark on host cell engineering to fine-tune the expression environment. In mammalian systems, such as CHO or HEK293 cells, we precisely modulate chaperone expression levels. This critical step is aimed at preventing the formation of inclusion bodies, which can hinder protein functionality and yield. By optimizing the cellular machinery, we create an ideal setting for robust and efficient protein expression, paving the way for high-quantity and high-quality protein harvests.

Step 3

Advanced Purification & Functional Activation

Once the proteins are expressed, the ADAM development service employs a sophisticated multi-step purification process. We utilize a combination of SEC (Size Exclusion Chromatography) and IEX (Ion Exchange Chromatography) techniques to achieve exceptional purity levels. Following purification, we carry out controlled pro-domain cleavage, a crucial step in activating the proteins to their fully functional forms.

Step 4

Rigorous Biophysical Validation

The final stage of our development process at ADAM Development Service involves rigorous biophysical validation. We employ Surface Plasmon Resonance (SPR) to analyze protein-ligand interactions in real-time, providing valuable insights into binding kinetics and affinity. Additionally, mass spectrometry is used to confirm the molecular weight and post-translational modifications of the proteins, ensuring their structural integrity and purity.

Fig. 2. ADAM development workflow. (Creative Biolabs AI) Fig 2 ADAM development blueprint.

Why Choose Us?

Unparalleled Expertise in Enzyme Engineering
ADAM development service boasts a team of seasoned experts with extensive experience in enzyme engineering. Their in-depth knowledge ensures top - notch solutions for your protein - related projects, giving you a competitive edge.

Comprehensive Multi-Step Purification Process
We employ a sophisticated multi-step purification process using SEC and IEX. This guarantees a highly pure enzyme, free from contaminants, which is crucial for reliable downstream applications and research outcomes.

Advanced Assay Technologies for Accurate Validation
With cell-based shedding assays, we provide accurate validation of protein functionality and inhibitor efficacy. This data-driven approach ensures you make informed decisions in your development pipeline.

Stringent Biophysical Validation for Quality Assurance
ADAM development service conducts rigorous biophysical validation using SPR and Mass Spectrometry. This final check confirms enzyme structural integrity and purity, delivering products that meet the highest industry standards.

Applications

Pharmaceutical Research

In pharmaceutical research, the ADAM development service plays a pivotal role. By studying ADAMs, we can identify novel drug targets. This aids in developing drugs for diseases like cancer and autoimmune disorders, opening new therapeutic avenues.

Biomarker Discovery

ADAMs are potential biomarkers. Our service helps in discovering and validating ADAM - related biomarkers. This enables early disease detection, allowing for timely intervention and better patient prognosis in various medical conditions.

Tissue Engineering

ADAMs are involved in cell - matrix interactions. Our development service provides tools to manipulate ADAMs, which can enhance tissue engineering. It helps in creating more functional and viable tissues for regenerative medicine applications.

Cancer Biology

ADAMs contribute to tumor cell invasion and metastasis. Through our service, researchers can study ADAM functions in cancer biology. This knowledge is crucial for developing strategies to inhibit tumor progression and improve cancer treatment outcomes.

Immunology Research

ADAMs are key regulators of immune cell function. Our service offers ways to investigate how ADAMs influence immune responses. This can lead to the development of immunomodulatory drugs for treating immune - related diseases.

Uncover Our Unique Support Approaches

Customer Reviews

Enhanced Mechanistic Insight
"Leveraging the ADAM development service in our research has profoundly accelerated our comprehension of Notch-signaling inhibition mechanisms in T-cell acute lymphoblastic leukemia, providing critical insights for targeted therapeutic strategies"- 4 months ago, Dr. Al*** J.

Toxicity Mitigation
"Incorporating the ADAM development service into our research not only revitalized our metalloproteinase program but also overcame critical challenges in specificity. Their innovative exosite-targeting approach effectively mitigated off-target toxicity issues that plagued traditional active-site inhibitors, enabling safer and more efficient therapeutic development."- 7 months ago, Dr. Mich*** W.

FAQs

Q: What is the main focus of your ADAM development service?

A: Our ADAM development service is centered around comprehensively studying ADAMs. We offer services including gene cloning and expression of ADAMs, functional analysis of their proteolytic and adhesive properties, and the development of inhibitors or modulators targeting specific ADAMs for research and potential therapeutic applications.

Q: How do you ensure the quality of ADAM gene cloning and expression in your service?

A: We utilize advanced molecular biology techniques and optimized expression systems. For gene cloning, we employ high-fidelity PCR and precise cloning strategies. In terms of expression, we screen different host cells and optimize culture conditions to achieve high - level and correct folding of ADAM proteins, which is then verified through various quality control assays.

Q: What kind of functional analysis do you conduct on ADAMs?

A: Our functional analysis covers multiple aspects. We assess the proteolytic activity of ADAMs using specific substrates and enzymatic assays. For the disintegrin domain, we study cell - adhesion and cell - migration assays to understand its role in cell - cell and cell-matrix interactions. Additionally, we can analyze the impact of ADAMs on signal transduction pathways in cells.

Q: Can you develop custom - made ADAM inhibitors or modulators?

A: Absolutely. Based on the structural and functional characteristics of specific ADAMs, our team of experts can design and screen for small - molecule inhibitors, antibodies, or other types of modulators. We use a combination of in - silico docking studies, high - throughput screening, and subsequent optimization to develop potent and selective ADAM - targeting agents.

Extended Services

Glycoproteomics-based Liquid-biopsy Laboratory Developed Test (LDT) Development Services

Creative Biolabs offers clinical-grade glycoproteomic liquid biopsy LDT development, enabling non-invasive cancer biomarker discovery.

Glyco-based Vaccine Development Service

Creative Biolabs provides end-to-end glyco-vaccine development, integrating glycoengineering of antigenic epitopes with immunogenicity optimization for next-generation cancer and infectious disease vaccines.

Creative Biolabs provides a high-precision, 20-year-proven platform for ADAM Development. From sequence optimization to allosteric inhibitor validation, we provide the technical depth necessary to conquer the challenges of proteolysis-targeted drug discovery. Contact our team for more information.

Reference

Lukaszewicz-Zajac, Marta, Sara Paczek, and Barbara Mroczko. "A disintegrin and metalloproteinase (ADAM) family—Novel biomarkers of selected gastrointestinal (GI) malignancies?" Cancers 14.9 (2022): 2307. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/cancers14092307.

For Research Use Only.

Related Services

Online Inquiry